Related Experiment Video
Updated: Jan 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Relationship between lung function impairment, clinical characteristics and systemic inflammation based on a
Xiaojun Ma1,2,3,4,5, Yan Yu6, Wenxia Guan2
1Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
This study identified distinct clinical phenotypes for lung function impairment and Preserved Ratio Impaired Spirometry (PRISm) in China. Machine learning models can predict these conditions, with specific cytokines indicating potential early biomarkers.
Area of Science:
- Pulmonary Medicine
- Epidemiology
- Biomarkers
Background:
- Chronic airway diseases like COPD are underdiagnosed in China.
- Preserved Ratio Impaired Spirometry (PRISm) may indicate early lung function impairment.
- Understanding PRISm phenotypes and systemic inflammation is crucial for early detection.
Purpose of the Study:
- Describe clinical phenotypes of lung function impairment in a Chinese population.
- Identify predictive factors for lung function impairment using machine learning.
- Explore the role of systemic inflammation in lung function impairment.
Main Methods:
- Prospective cross-sectional study in Hongtong County, China (2021-2024).
- Spirometry classified participants into airflow obstruction, PRISm, and normal groups.
- Machine learning models were developed to predict lung function impairment; serum cytokines were measured.
Main Results:
- 51.0% had airflow obstruction, 6.7% had PRISm, 42.3% were normal among 9,284 adults.
- PRISm group: predominantly female, lower smoking rates, higher coronary heart disease risk.
- Airflow obstruction group: older, male, lower BMI, smokers, with renal/cerebrovascular comorbidities.
- Machine learning identified age, sex, BMI, symptoms, creatinine, and hemoglobin as predictors (AUC=0.635).
- Airflow obstruction and PRISm groups showed lower IL-2 and higher IL-5/IL-17A serum levels.
Conclusions:
- Distinct clinical phenotypes exist for airflow obstruction and PRISm.
- A predictive model using clinical variables aids in identifying individuals at risk for lung function impairment.
- Serum IL-2, IL-5, and IL-17A may serve as biomarkers for early lung function impairment detection.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...